Variable | Group F (n=21) | Group P (n=20) | P |
---|---|---|---|
Age (y); (mean ± SD) | 78.67±5.92 | 76.45±4.56 | 0.188 |
BMI (kg.m-2); median (IQR) | 20.2 (19.1-22.8) | 22.16 (20.1-23.6) | 0.262 |
Female/ Male (n/n) | 18/3 | 16/4 | 0.697 |
Left/Right side fracture (n/n) | 11/10 | 12/8 | 0.623 |
Transcervical fracture/ Intertrochanter fracture of femur (n/n) | 17/4 | 15/5 | 0.719 |
ASA physical status; I/ II/ III (n/n/n) | 2/5/14 | 3/7/10 | 0.595 |
Basic disease | |||
Coronary disease; n (%) | 7 (33) | 6 (30) | 0.819 |
Cerebral infarction;n (%) | 18 (85.7) | 14 (70) | 0.179 |
Diabetes; n (%) | 4 (19) | 2 (10) | 0.663 |
Hypertension; n (%) | 8 (38.1) | 12 (60) | 0.161 |
Respiratory disease; n (%) | 3 (14.3) | 1 (5) | 0.606 |
Other diseases; n (%) | 10 (47.6) | 12 (60) | 0.427 |
MAP before intervention; (mean ± SD) | 81.43±7.79 | 85.7±9.71 | 0.127 |
HR before intervention; (mean ± SD) | 82.10±5.63 | 81.95±5.94 | 0.936 |
SpO2 before intervention; median (IQR) | 98 (96-98) | 98 (97-98) | 0.140 |
Dynamic NRS score before intervention; median (IQR) | 9 (8-10) | 9 (6-10) | 0.146 |
Static NRS score before intervention; median (IQR) | 4 (4-5) | 4.5 (3-5) | 0.463 |